MicroPort NeuroTech Limited Board announced that Mr. Peng Bo (Mr. Peng) has resigned as a non-executive Director, the Chairman, a member of the Remuneration Committee, Authorized Representative, and a director and the chairman of MicroPort NeuroTech, with effect from November 3, 2023 due to retirement. Dr. Chang Zhaohua (Dr. Chang) has been appointed as a non-executive Director and the Chairman, with effect from the same date. Mr. Xie Zhiyong has been appointed as a member of Remuneration Committee, Authorized Representative, and the chairman of MicroPort NeuroTech, with effect from the same date.

Mr. Sun Qingwei (Mr. Sun) has been appointed as a non-executive Director and a director of MicroPort NeuroTech, with effect from the same date. Mr. Peng has confirmed to the Company that he does not have any disagreement with the Board and that there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company and/or the Stock Exchange. Dr. Chang, born in 1963, is the current chairman of the board of directors, executive director and chief executive officer of MicroPort.

He has over 32 years' experience in the medical device industry, and currently also serve as a professor at School of Medical Device, University of Shanghai for Science and Technology. Before establishing Shanghai MicroPort Medical (Group) Co. Ltd. in 1998, from 1996 to 1997, Dr. Chang served as vice president of R&D at Endocare Inc., a NASDAQ listed medical device company based in California, U.S. From 1990 to 1995, Dr. Chang served as senior engineer, chief scientist, director of R&D and vice president of engineering at Cryomedical Sciences Inc., a medical device company in Maryland U.S. which was listed on NASDAQ prior to its acquisition by a third party.

Dr. Chang received his bachelor's degree in refrigeration engineering in 1983 and master's degree in cryogenic engineering in 1985, both from University of Shanghai for Science and Technology. In 1992, he received his doctoral degree in biological science from State University of New York (Binghamton). Dr. Chang has published extensively in biomedical fields and holds several dozens of patents in China and the United States.

Dr. Chang shall only hold office until the next annual general meeting of the Company and will be eligible for and subject to re-election at such meeting in accordance with the articles of association of the Company. Mr. Sun, born in 1983, joined MicroPort in October 2018 and has held various positions including assistant to the CEO and senior director of strategy and planning. During that period, he was responsible for the strategic planning and operation of the company, leading the strategic layout and assisting dozens of MicroPort's subsidiaries to establish medium to long-term development plans.

He has also pioneered a number of emerging areas and led the start-up development of new businesses. Prior to joining MicroPort, Mr. Sun accumulated many years of experience in pharmaceutical and life science consulting in Boston, U.S., where he conducted in-depth research in the areas of biopharmaceuticals, medical devices, diagnostics, and healthcare services. Mr. Sun graduated from Kyoto University of Japan in 2007 with a bachelor's degree in engineering science, majoring in materials science and engineering, and obtained a master's degree in materials engineering from Kyoto University of Japan in 2009.

Mr. Sun attended Harvard School of Public Health since 2009 and obtained a master's degree in environmental health in 2011. Mr. Sun shall only hold office until the next annual general meeting of the Company and will be eligible for and subject to re-election at such meeting in accordance with the articles of association of the Company.